TAI:4169
TCM Biotech International Corp. · TAI · Healthcare · TWD · FY for 2025
Figures on this page computed 2026-11-07 16:10 UTC
Last close
n/aTWD
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
357.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
- Computed from the filing for 2025
1.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
2.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
5.3%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.04Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.3%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
Price is the furthest below its sector's middle: 0.08 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.02x
Its own average over 10 years, 671.8M.
- Profit1.02x
Its own average over 10 years, 18.8M.
- Free cash flow-6.58x
Its own average over 10 years, -5.6M.
- Debt0.37x
Its own average over 10 years, 116.7M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at -6.58 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 106.9 | 57.6 | 100.0 |
| 2018-12-31 | 106.8 | 75.4 | 95.8 |
| 2019-12-31 | 112.4 | 19.8 | 98.6 |
| 2020-12-31 | 145.7 | 77.7 | 98.5 |
| 2021-12-31 | 138.8 | 5.7 | 98.9 |
| 2022-12-31 | 158.6 | 55.5 | 95.8 |
| 2023-12-31 | 191.7 | 56.5 | 103.4 |
| 2024-12-31 | 131.8 | 63.9 | 115.2 |
| 2025-12-31 | 135.5 | 58.3 | 115.2 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TWD
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TWD
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TWD
Figures behind the shape
Growth
-1.4%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate-1.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
Five-year EPS growth rate-8.9%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
One-year change in net income-8.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
Returns on capital
1.9%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capital1.9%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity1.8%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets1.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
43.3%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin43.3%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin2.7%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin2.8%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin5.3%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
357.8xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings357.8x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
- Computed from the filing for 2025
Price to book6.4x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA155.5x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio9.9x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.04safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equity0.04
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio7.47
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage21.6x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score28.65
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
0.3%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yield0.3%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
Payout ratio107.8%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio1.8x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- TWD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.